A Novel Function of Molecular Chaperone HSP70

Targeting FOXM1 auto-regulation in cancer

(2015) Andrei L Gartel   CANCER BIOLOGY & THERAPY

Inference of transcriptional regulation in cancers

(2015) Peng Jiang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Hsp70 in cancer: back to the future

(2014) M Y Sherman et al.   ONCOGENE

SPDEF Inhibits Prostate Carcinogenesis by Disrupting a Positive Feedback Loop in Regulation of the Foxm1 Oncogene

(2014) Xin-Hua Cheng et al.   PLoS Genetics

ROS inhibitorN-acetyl-L-cysteine antagonizes the activity of proteasome inhibitors

(2013) Marianna Halasi et al.   BIOCHEMICAL JOURNAL

Hsp70 silencing with siRNA in nanocarriers enhances cancer cell death induced by the inhibitor of Hsp90

(2013) Mirela Matokanovic et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

FOX(M1) News--It Is Cancer

(2013) M. Halasi et al.   MOLECULAR CANCER THERAPEUTICS

Hsp70 chaperone dynamics and molecular mechanism

(2013) Matthias P. Mayer   TRENDS IN BIOCHEMICAL SCIENCES

Targeting FOXM1 in cancer

(2012) Marianna Halasi et al.   BIOCHEMICAL PHARMACOLOGY

Inhibition of HSP70: A challenging anti-cancer strategy

(2012) Anastasia R. Goloudina et al.   CANCER LETTERS

Abstract 4329: In vitro and in vivo antitumor effects of gemcitabine in a murine head and neck squamous cell carcinoma (HNSCC) model

(2012) Anren Song et al.   CANCER RESEARCH

Thiostrepton, proteasome inhibitors and FOXM1

(2012) Andrei L. Gartel   CELL CYCLE

A novel mode of FoxM1 regulation: Positive auto-regulatory loop

(2011) Marianna Halasi et al.   CELL CYCLE

Anti-malaria drug blocks proteotoxic stress response: Anti-cancer implications

(2011) Nickolay Neznanov et al.   CELL CYCLE

FoxM1 knockdown sensitizes human cancer cells to proteasome inhibitor-induced apoptosis but not to autophagy

(2011) Bulbul Pandit et al.   CELL CYCLE

Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells

(2011) Bin Bao et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

ATM and p53 Regulate FOXM1 Expression via E2F in Breast Cancer Epirubicin Treatment and Resistance

(2011) J. Millour et al.   MOLECULAR CANCER THERAPEUTICS

Proteasome inhibitors in cancer therapy

(2011) Lisa J. Crawford et al.   Journal of Cell Communication and Signaling

FoxM1 Mediates Resistance to Herceptin and Paclitaxel

(2010) Janai R. Carr et al.   CANCER RESEARCH

Novel anticancer compounds induce apoptosis in melanoma cells

(2010) Uppoor G. Bhat et al.   CELL CYCLE

A new target for proteasome inhibitors: FoxM1

(2010) Andrei L Gartel   EXPERT OPINION ON INVESTIGATIONAL DRUGS

FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells

(2010) J. M.-M. Kwok et al.   MOLECULAR CANCER RESEARCH

Genome-wide Analysis using ChIP to Identify Isoform-specific Gene Targets

(2010) Michael L. Beshiri et al.   Jove-Journal of Visualized Experiments

p21WAF1/CIP1and cancer: A shifting paradigm?

(2009) Andrei L. Gartel   BIOFACTORS

FoxM1 Is a General Target for Proteasome Inhibitors

(2009) Uppoor G. Bhat et al.   PLoS One